Scientist Webinar: CAR T-cell Therapy Bispecific Antibodies: Frontiers in Cancer Immunotherapy

FREE Scientist Webinar: Cancers are the most heterogenous group of diseases affecting humans. Multiple compensating pathways work to promote disease progression. Various immunotherapies have shown anticancer promise, but the their targeted nature limits the scope of their action and applicability. CAR T-cell therapy and bispecific antibodies are two approaches that have addressed the targeting of more than one epitope, the re-directing of T lymphocytes to kill tumor cells, and the improvement of efficacy in solid tumor types. For a closer look at the design, development, and success of CAR T-cell therapy and bispecific antibodies, The Scientist is bringing together a panel of experts to discuss their research and share insights into the potential these therapeutics hold in the fight against various tumor types. Join us to get your questions answered by our esteemed panel. Topics to be covered: Where cancer immunotherapies are living up to their promise, and where they’re falling short; and The art and science of developing novel immunotherapies
Thursday, May 24, 2018 - 2:30pm
State, Province or Country: 
Event Time Zone: 
Daylight Savings Time